GeriaSan

GeriaSan is a Swiss-based biotechnology company focused on developing and commercializing evidence-based solutions for healthy aging and geriatric care. The company specializes in the research of metabolic pathways associated with longevity, specifically targeting mechanisms like sirtuin activation and mTOR inhibition to address age-related conditions such as sarcopenia and cognitive decline. GeriaSan bridges the gap between pharmaceutical research and high-end nutraceuticals, offering products designed to maintain physical and mental vitality in the elderly. Their business model encompasses both the development of proprietary formulations and the provision of specialized health services for the geriatric population.